Muammer Altok

About

Dr. Muammer Altok is a leading urologic oncologist whose research centers on improving surgical precision and outcomes in prostate cancer management. His work has fundamentally advanced our understanding of robot-assisted radical prostatectomy (RARP), particularly in the critical areas of lymph node staging and Gleason score accuracy. In his highly cited 2018 study (30 citations), Dr. Altok pioneered surgeon-led pathological staging of pelvic lymph node metastases during RARP, establishing evidence-based templates that optimize patient selection and reduce unnecessary dissection. His 2019 investigation (23 citations) addressed the persistent challenge of biopsy-to-specimen Gleason score discordance, demonstrating how routine clinical features can predict "regression to the mean" and correlate with biochemical relapse rates—a finding that directly refines risk stratification for localized prostate cancer. Beyond these contributions, Dr. Altok has shaped surgical education through his 2017 study on RARP training (12 citations), developing time-based metrics and qualitative grading systems for fellows and residents. His work bridges the gap between technical innovation and clinical decision-making, providing surgeons with actionable frameworks to improve staging accuracy, reduce overtreatment, and enhance training outcomes in robotic prostate surgery.

Research Focus

Key Achievements

Top Papers

1. 1
   Surgeon‐led prostate cancer lymph node staging: pathological outcomes stratified by robot‐assisted dissection templates and patient selection

   30 citations · 2018
2. 2
   Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of “regression to the mean” using routine clinical features with correlating biochemical relapse rates

   23 citations · 2019
3. 3
   A decade of robot-assisted radical prostatectomy training: Time-based metrics and qualitative grading for fellows and residents

   12 citations · 2017

Key Collaborators

Contact & Links